• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Lesch-Nyhan Syndrome

Lesch-Nyhan Syndrome - 4 Studies Found

Completed : Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease
: Lesch-Nyhan Syndrome
: 1999-10-18
: Drug: aminomidazole carboxamide riboside
Withdrawn : Trial of Kuvan in Lesch-Nyhan Disease
: Behavioral Manifestations of Lesch-Nyhan Disease
: 2009-07-08
: Drug: sapropterin oral 100mg tablets taken intact or dissolved in water or apple juice with morning meal
Completed : Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease
: Lesch-Nyhan Disease
: 2010-02-06
: Drug: Ecopipam Tablets, once daily, for two weeks up to 200 mg/day
Terminated : Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
:
  • Lesch-Nyhan Disease
  • Self-injurious Behavior

: 2012-12-14
:
  • Drug: Ecopipam Antagonist of t

Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.